Gene Query: CORO1C

Dataset Description Geneva Score
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 52.81
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 52.81
EP400 is required for Max and MCPyV mediated gene activation 48.85
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 44.92
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 35.29
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 35.29
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 35.17
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 34.38
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 30.54
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 30.05
Differential analysis of gene regulation at transcript resolution by RNA-Seq 30.05
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 29.93
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 28.6
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 28.07
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 27.19
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 26.66
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 26.14
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 25.65
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 24.64
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 24.11
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 23.91
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 23.8
RNA-Seq analysis of breast cancer cells after shikonin treatment 23.68
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 23.09
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 22.85
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 22.79
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 22.6
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 22.43
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 22.25
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 22.09
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 22.09
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 21.99
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 21.94
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 21.83
Active translatome profiling with RiboLace in MCF7 cells 21.41
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 21.28
An RNA-centric dissection of host complexes controlling flavivirus infection 21.28
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 21.27
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 21.17
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 20.62
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 20.54
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 20.21
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 19.72
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 19.65
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 19.53
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 19.49
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 19.49
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 19.21
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 19.06
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 19.02
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 19.02
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 18.99
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 18.99
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 18.94
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 18.67
RIG-I and MDA5 fRIP during KSHV lytic reactivation 18.29
RNA-sequencing in irradiated and normal A549 cells. 17.87
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 17.86
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 17.19
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 17.19
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 17.18
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 17.18
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 17.13
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 17.08
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 16.79
Tracing Enhancer Networks using Epigenetic Traits (TENET) 16.77
Seletive inhibition of CDK9 in DLBCL cell lines 16.55
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 16.37
Cleavage Factor Im as a key regulator of 3’ UTR length 16.24
CircRNAome diversity in human mature B-cells, T-cells and monocytes 16.24
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 16.2
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 15.96
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 15.94
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 15.84
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 15.84
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 15.78
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 15.75
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 15.64
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 15.51
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 15.51
Genome wide miR-191 target profile determined by RIP and gene expression profiling 15.51
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 15.51
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 15.38
Gene expression regulated by CSA and CSB in neuroblastoma cell line 15.28
Modeling Familial Cancer with iPSC Approaches 15.11
The pause-initiation limit restricts transcription activation in human cells 15.02
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 14.98
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 14.96
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 14.77
RNAseq of HEK293 cells after Chtop knockdown 14.61
Co-transcriptional loading of RNA export factors shapes the human transcriptome 14.61
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 14.58
RNA-seq analyses of human prostate cancer cells 14.55
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 14.4
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 14.25
Gene expression changes caused by KRAS in MCF-10A 14.23
MYCi361 regulates MYC target genes 14.17
TOP2B disturbed the quality of human oocytes with advanced maternal age 14.0
Expression by CD133+ cells isolated from the adult human exocrine pancreas 13.89
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 13.84
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 13.81
Transcriptome profiling of Normal and Cancerous Prostate Cells 13.79
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 13.59
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 13.59
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 13.58
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 13.56
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 13.53
NRDE2 negatively regulates nuclear exosome functions 13.46
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 13.37
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 13.33
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 13.24
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 13.24
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 13.18
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 13.13
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 13.03
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 13.02
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 13.02
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 12.94
Regulation of highly expressed hCINAP on translatome 12.88
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 12.75
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 12.7
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 12.65
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 12.65
3’ Uridylation Expands miRNA Target Repertoire 12.65
Aging-associated patterns in the expression of human endogenous retroviruses 12.6
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 12.35
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 12.33
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 12.3
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 12.23
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 12.23
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 12.13
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 12.13
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 12.13
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 11.97
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 11.95
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 11.91
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 11.88
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 11.86
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 11.82
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 11.8
The human blood-nerve barrier transcriptome 11.8
The Genomic Landscape of Atypical Fibroxanthoma 11.78
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 11.73
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 11.68
circRNA-sequencing 11.68
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 11.57
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 11.57
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 11.56
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 11.49
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 11.48
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 11.47
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 11.41
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 11.37
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 11.33
Systematic discovery of endogenous human ribonucleoprotein complexes 11.3
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 11.28
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 11.27
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 11.27
Transcriptomic profile of human embryonic renal corpuscles 11.24
Ribosomal footprinting of CN34-Parental and CN34-LM1a 11.24
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 11.22
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 11.19
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 11.15
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 11.14
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 11.1
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 11.07
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 10.99
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 10.93
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 10.86
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 10.86
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 10.75
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 10.66
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 10.64
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 10.62
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 10.61
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 10.6
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 10.58
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 10.54
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 10.5
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 10.46
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 10.46
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 10.46
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 10.44
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 10.44
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 10.35
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 10.19
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 10.16
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 10.16
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 10.16
Lipid degradation promotes prostate cancer cell survival 10.15
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 10.14
HNRNPL and its RNA Targets in Prostate Cancer 10.14
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 10.12
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 9.86
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 9.84
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.81
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 9.79
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 9.76
High-throughput sequencing of pluripotent cells 9.75
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 9.74
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 9.74
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 9.74
Entrectinib Resistance in a Neuroblastoma Xenograft Model 9.72
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 9.7
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 9.68
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 9.67
Co-regulation of splicing by Rbfox1 and hnRNP M 9.64
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 9.64
Ribosomal footprinting of MDA-Parental and MDA-LM2 9.61
Nutritional control of protein translation 9.59
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 9.57
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 9.54
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 9.49
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 9.49
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 9.49
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.49
Human Treg IFNg/IL-10 subpopulations 9.48
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 9.45
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 9.45
Be1 and Be2 B cells are transcriptionally distinct 9.42
Discovering human diabetes-risk gene function with genetics and physiological assays 9.42
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 9.35
Selective expression of long non-coding RNAs in a breast cancer cell progression model 9.31
Exploring the RNA landscape of endothelial exosomes 9.26
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 9.2
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 9.16
A role for ZNF598 in post-transcriptional gene regulation 9.14
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 9.11
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 8.99
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 8.92
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 8.89
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 8.89
A prostate cancer chromatin interaction map 8.89
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 8.87
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 8.87
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 8.86
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 8.79
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 8.73
Tpl-2 small molecule project 8.7
Tpl-2 and MEK small molecule inhibitors 8.7
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 8.69
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 8.69
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 8.64
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 8.57
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 8.55
Transcriptional profiles of normal human mature B cells 8.55
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 8.48
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 8.46
RNA-Seq in neutrophils from Antiphospholipid Syndrome 8.44
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 8.41
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 8.39
Proliferation-correlated expression 8.38
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 8.36
Differetially expressed genes after hTR overexpression in U2OS cells 8.34
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 8.28
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 8.24
Overexpression and knockdown experiment for circCSNK1G3 8.21
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 8.14
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 8.12
MRTF activates TEAD-YAP target gene expression 8.11
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 7.96
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 7.96
Transcription elongation regulates genome 3D structure 7.88
Total RNA-seq in ALL-SIL upon JQ1 inhibition 7.87
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 7.67
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 7.67
Mechanistic Model-Guided Study of Embryonic Morphogenesis 7.64
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 7.58
ZIKV infection of monocytes activates inflammasome pathways 7.55
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 7.54
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 7.49
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 7.47
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 7.47
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 7.46
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 7.38
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 7.36
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 7.34
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 7.3
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 7.25
BCL11B 7.18
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 7.08
Transcriptomic analysis of the HOTAIR-regulated genes 7.01
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 6.95
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 6.9
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 6.87
Genome-wide Analysis of Chromatin Interactions in Human Cells 6.86
BASP1 modifies the Tamoxifen response 6.83
METTL3 and WTAP 6.81
Energy Metabolism during Anchorage-Independence 6.73
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 6.72
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 6.71
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 6.71
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 6.71
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 6.69
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 6.6
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 6.54
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 6.54
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 6.54
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 6.49
RNA-Seq in PWS iPSC-derived neurons 6.4
Recovery and analysis of nascent RNA 6.35
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 6.35
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.35
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.33
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 6.21
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 6.19
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 6.01
Transcriptional profile in human S. haematobium infection 5.94
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 5.94
Characterization of human ILC2 subsets 5.89
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 5.84
MAIT cell RNA sequencing 5.74
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 5.69
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 5.56
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 5.55
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 5.5
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 5.49
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.47
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 5.46
Noncoding regions are the main source of targetable tumor-specific antigens 5.44
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 5.37
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 5.36
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.35
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 5.31
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 5.3
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 5.28
Intron retention induced by microsatellite expansions as a disease biomarker. 5.27
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 5.27
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 5.24
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.01
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.87
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 4.85
Generation and functional characterization of MDSC-like cells 4.78
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 4.77
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 4.69
LINE-2 transposable elements are a source of functional human microRNAs and target sites 4.61
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 4.6
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 4.57
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.53
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.49
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.39
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 4.37
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 4.37
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 4.35
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 4.3
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 4.23
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 4.23
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 4.09
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 4.09
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.9
RNA seq_PDX2_SHP099 3.9
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.89
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 3.87
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 3.87
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 3.84
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.8
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.8
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.8
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 3.79
Global response to chemotherapy-induced apoptosis 3.77
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 3.76
Human Treg IL-12 stimulation 3.75
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 3.65
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 3.64
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 3.64
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.62
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.61
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.61
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.59
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.55
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 3.54
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.44
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 3.43
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 3.43
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 3.41
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 3.4
Hepatocyte maturation 3.37
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.27
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.23
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.2
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.2
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 3.18
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 3.18
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 3.12
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 3.03
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 2.97
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 2.96
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.94
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 2.93
Gene Expression Profiling of WT and KDM3A Knocked out Cell 2.9
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 2.9
Exogenous rescue of KLHL9 in SF210 cell line 2.83
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 2.77
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 2.76
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.76
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.76
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.71
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.7
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.64
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.53
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.53
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 2.51
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 2.51
RNA expression analysis upon JMJD1C depletion 2.48
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.48
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.48
miR-93 Targets in Human Endothelial Cells 2.44
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.43
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 2.42
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2.38
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 2.36
Zika virus directly infects human peripheral neurons and induces cell death 2.33
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 2.31
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 2.3
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.22
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.19
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 2.09
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.09
Anti-inflammatory effect of indoleacrylic acid (IA) 2.09
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 2.06
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.01
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 2.01
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 1.96
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.92
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.92
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.84
Comparative Analysis of Cas9 Activators Across Multiple Species 1.81
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 1.78
Human Treg NaCl stimulation 1.73
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 1.67
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.66
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.58
Metabolism as an early predictor of DPSCs aging 1.56
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 1.5
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.46
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.42
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 1.39
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.37
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 1.32
Evaluating pre-clinical models for studying NASH driven HCC. 1.28
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.26
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.22
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.12
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.12
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.1
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.08
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.06
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.04
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.98
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.95
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.95
IMP3 regulated gene expression in breast cancer cells 0.92
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.91
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.89
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.89
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.86
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.85
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.84
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.84
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.84
Solid phase chemistry to covalently and reversibly capture thiolated RNA 0.83
Transcriptome-wide response to synthetic chromatin protein PcTF 0.81
Identification of long noncoding RNAs in T-ALL cell lines 0.81
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.76
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.68
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.66
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.66
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 0.61
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.55
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 0.54
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.54
The role of m6A/m-RNA methylation in stress response regulation 0.54
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.51
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.48
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 0.41
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.41
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.41
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.41
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.38
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.37
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.33
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.32
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.29
Determining mRNA half-lives on a transcriptome-wide scale 0.26
RNA-seq of IL-4 stimulated human keratinocytes 0.26
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.26
Myc activation coordinates gene transcription and protein translation responses 0.25
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.25
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.21
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 0.21
HNRNPM-regulated splicing dependencies in prostate cancer 0.21
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.21
Expression analysis of the TAF1 syndrome 0.19
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.18
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.13
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.11
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.1
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.1
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.08
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.05


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation